Shiyi Ye

Dr. Shiyi Ye

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
FSFei Su
Fei Su
LXLihua Xu
Lihua Xu
YXYin Xue
Yin Xue
WXWei Xu
Wei Xu
JLJunxing Li
Junxing Li
XYXiufang Yuan
Xiufang Yuan
Porcine epidemic diarrhea virus (PEDV) causes severe enteric disease in pigs, particularly neonatal piglets. Current vaccines do not provide complete protection against PEDV. Ginseng stem-leaf saponins (GSLS), a promising oral adjuvant candidate, can improve intestinal immune responses in poultry and mice. However, its low stability limits further use. Poly lactic-co-glycolic acid (PLGA), a biocompatible and biodegradable nanoparticle, has been widely used in biomedicine for stable and targeted drug delivery. In this study, we developed GSLS-PLGA nanoparticles (GSLS-NPs) and evaluated the mucosal adjuvant efficacy in vitro and in vivo. GSLS-NPs significantly enhanced antigen internalization and pro-inflammatory cytokine secretion by DC2.4 cells. Mice orally administered GSLS-NPs before intramuscular inoculation generated CD11b+CD8α− and CD11b−CD103+ dendritic cells in the spleen and draining mesenteric lymph nodes, respectively, which are the types mainly responsible for antigen presentation. Additionally, enhanced neutralizing and non-neutralizing antibody responses and expanded activities of specific effector and memory CD4+ and CD8+ T cells were also observed in mice immunized with PEDV vaccines plus GSLS-NPs compared to mice receiving the vaccines alone. Furthermore, GSLS-NPs showed a good safety profile and presented great advantages over GSLS aqueous solution. Collectively, our results highlight the potential of GSLS-NPs as a mucosal adjuvant and provide an attractive vaccination strategy for combatting PEDV. Further study is required to evaluate the efficacy of this mucosal adjuvant in swine.

12 April 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
FSFei Su
Fei Su
JLJunxing Li
Junxing Li
YXYin Xue
Yin Xue
BYBin Yu
Bin Yu
SYShiyi Ye
Shiyi Ye
XYXiufang Yuan
Xiufang Yuan
Neonatal piglets during the first week of life are highly susceptible to porcine epidemic diarrhoea virus (PEDV) infection, with mortality rates reaching 80–100%. Passive lactogenic immunity remains the most effective way to protect neonates from infection. Although safe, inactivated vaccines provide little or no passive protection. Here, we administered ginseng stem-leaf saponins (GSLS) to mice before parenteral immunization with an inactivated PEDV vaccine to investigate the effect of GSLS on the gut–mammary gland (MG)–secretory IgA axis. Early oral GSLS administration potently increased PEDV-specific IgA plasma cell generation in the intestine, facilitated intestinal IgA plasma cell migration to the MG by enhancing the chemokine receptor (CCR)10-chemokine ligand (CCL)28 interaction, and ultimately promoted specific IgA secretion into milk, which was dependent on Peyer’s patches (PPs). Additionally, GSLS improved the gut microbiota composition, especially increasing probiotic abundance, and these microflora members promoted the GSLS-enhanced gut–MG–secretory IgA axis response and were regulated by PPs. In summary, our findings highlight the potential of GSLS as an oral adjuvant for PEDV-inactivated vaccines and provide an attractive vaccination strategy for lactogenic immunity induction in sows. Further studies are required to evaluate the mucosal immune enhancement efficacy of GSLS in pigs.

7 May 2026 in Advanced Materials
Verified
Journal Article
Closed access
KSKang Shao
Kang Shao
HWHaoru Wen
Haoru Wen
WXWuyan Xie
Wuyan Xie
QDQibin Dong
Qibin Dong
YMYing Meng
Ying Meng
JWJing Wang
Jing Wang

9 October 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
FSFei Su
Fei Su
LXLihua Xu
Lihua Xu
YXYin Xue
Yin Xue
WXWei Xu
Wei Xu
JLJunxing Li
Junxing Li
XYXiufang Yuan
Xiufang Yuan
Porcine epidemic diarrhea virus (PEDV) causes severe enteric disease in pigs, particularly neonatal piglets. Attempts to develop a safe and effective vaccine have been unsuccessful. Ginseng stem-leaf saponins (GSLS), a promising oral adjuvant candidate, can improve intestinal immune responses in poultry and mice. However, the low stability limits the further use. Poly lactic-co-glycolic acid (PLGA), a biocompatible and biodegradable nanoparticle, have been widely used in biomedicine for stable and targeted drug delivery. In this study, we developed GSLS-PLGA nanoparticles (GSLS-NPs) and evaluated the mucosal adjuvant efficacy in vitro and in vivo. GSLS-NPs significantly enhanced antigen internalization and pro-inflammatory cytokine secretion by DC2.4 cells. Mice orally administered GSLS-NPs before intramuscular inoculation generated CD11b+CD8α- and CD11b-CD103+ dendritic cells in the spleen and draining mesenteric lymph nodes, respectively, which are the types mainly responsible for antigen presentation. Additionally, enhanced neutralizing and non-neutralizing antibody responses and expanded activities of specific effector and memory CD4+ and CD8+ T cells were also observed in mice immunized with PEDV vaccines plus GSLS-NPs compared to mice receiving the vaccines alone. Furthermore, GSLS-NPs showed a good safety profile and presented great advantages over GSLS aqueous solution. Collectively, our results highlight the potential of GSLS-NPs as a mucosal adjuvant and provide an attractive vaccination strategy for combatting PEDV. Further study is required to evaluate the efficacy of this mucosal adjuvant in swine.

25 April 2026 in Advanced Optical Materials
Verified
Journal Article
Closed access
KSKang Shao
Kang Shao
QDQibin Dong
Qibin Dong
YMYing Meng
Ying Meng
JCJiahong Chen
Jiahong Chen
HWHaoru Wen
Haoru Wen
JWJing Wang
Jing Wang

Verified
Journal Article
Open access
PDF file
XYXiufang Yuan
Xiufang Yuan
BYBin Yu
Bin Yu
XMXingyuan Ma
Xingyuan Ma
LXLihua Xu
Lihua Xu
FSFei Su
Fei Su
SYShiyi Ye
Shiyi Ye
As a member of the Alphavirus genus, Getah virus (GETV) has become an emerging pathogen posing severe threats to animal health and public health security. In recent years, GETV has caused increasing outbreaks in swine herds, leading to substantial economic losses in the pig industry in China. Here, we report continuous GETV outbreaks on pig farms across southeastern China between September 2024 and December 2025. A total of 185 clinical samples were examined, among which 27 were positive (14.6%). Subsequently, five GETV strains were successfully isolated and subjected to whole-genome sequencing. Phylogenetic analysis revealed that all the 5 isolated strains belonged to genotype III(GIII), with two strains (GETV-AHX2024 and GETV-JS2024) forming a distinct GIII variant clade. Notably, multiple specific amino acid mutations were identified in the nsp3, C, E2, 6K, and E1 proteins and 3′UTR of these GIII variant strains. Pathogenicity in mice revealed that mice infected with the GIII variant strain GETV-JS2024 exhibited a longer viral shedding period compared with other strains. These findings highlight the emergence of GETV GIII variant strains in southeastern China and suggest their altered pathogenic performance in mice. These results supplied critical data for molecular surveillance and subsequent pathogenic analysis of GETV in China.